Researchers Who Discovered Hepatitis C Earn Nobel Prize
Researchers Who Discovered Hepatitis C Earn Nobel Prize
Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.
Researchers Who Discovered Hepatitis C Earn Nobel Prize
Researchers Who Discovered Hepatitis C Earn Nobel Prize

Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.

Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.

antiviral therapy
The Scientist Speaks Podcast - Episode 9
The Scientist Speaks Podcast - Episode 9
The Scientist Creative Services Team | Sep 29, 2020
Repurposing Living Systems to Fight a Pandemic
<strong>Combating COVID-19 with Cell-Free Expression</strong>
Combating COVID-19 with Cell-Free Expression
The Scientist Creative Services Team | Aug 19, 2020
Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Catherine Offord | Aug 11, 2020
Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.
AI Is Screening Billions of Molecules for Coronavirus Treatments
AI Is Screening Billions of Molecules for Coronavirus Treatments
Abby Olena | May 7, 2020
Machine learning has pegged existing drugs to repurpose for COVID-19 clinical trials.
Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials
Catherine Offord | Apr 30, 2020
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.
Chloroquine for COVID-19: Cutting Through the Hype
Chloroquine for COVID-19: Cutting Through the Hype
Chris Baraniuk | Mar 20, 2020
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.
Remdesivir Works Against Coronaviruses in the Lab
Remdesivir Works Against Coronaviruses in the Lab
Abby Olena | Mar 20, 2020
The antiviral disables RNA replication machinery in MERS and SARS viruses. Can it beat back SARS-CoV-2?
The Latest Drug Trials for Coronavirus
The Latest Drug Trials for Coronavirus
Ashley Yeager | Feb 18, 2020
Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.
Flu and HIV Drugs Show Efficacy Against Coronavirus
Flu and HIV Drugs Show Efficacy Against Coronavirus
Catherine Offord | Feb 3, 2020
Combining the medications improved conditions in patients with severe 2019-nCoV infections, say doctors in Thailand.